SUNREST — Sunrest Lifescience Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹229.58m
- IN₹281.02m
- IN₹294.83m
- 13
- 43
- 45
- 22
Annual cashflow statement for Sunrest Lifescience, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 2.24 | 10.5 | 27.4 | 5.93 |
| Depreciation | ||||
| Non-Cash Items | 0.076 | -0.116 | 0.591 | 2.18 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -1.21 | -15.5 | -17.8 | -157 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 1.53 | -4.49 | 11.5 | -148 |
| Capital Expenditures | -1.62 | -4.67 | -0.142 | -0.071 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | — | 1.1 | -0.165 | 0 |
| Sale of Fixed Assets | ||||
| Change in Net Investments | ||||
| Cash from Investing Activities | -1.62 | -3.56 | -0.307 | -0.071 |
| Financing Cash Flow Items | -0.075 | -0.108 | -0.591 | -2.18 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 0.381 | 9.12 | -11.5 | 146 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0.296 | 1.07 | -0.301 | -1.6 |